|
1
|
Cardenas Sanchez J and Sandoval Guerrero
F: Tercera Revisión del Consenso Nacional Sobre el Diagnóstico y
Tratamiento del Cáncer Mamario. Ginecol Obstet Mex. 78:199–212.
2010.
|
|
2
|
Cummings MC, Aubele M, Aubele M, et al:
Increasing chromosome 1 copy Lumber parallels histological
progression in breast carcinogenesis. Br J Cancer. 82:1204–1210.
2000.PubMed/NCBI
|
|
3
|
Visscher DW, Wallis TL and Crissman JD:
Evaluation of chromosome aneuploidy in tissue sections of
preinvasive breast carcinomas using interphase cytogenetics.
Cancer. 77:315–320. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rojas-Atencio A, González L, Urdaneta K,
et al: Cytogenetic findings in ductal carcinoma of the breast.
Invest Clin. 40:179–189. 1999.PubMed/NCBI
|
|
5
|
Bieche I and Lidereau R: Genetic
alterations in breast cancer. Genes Chromosomes Cancer. 14:227–251.
1995. View Article : Google Scholar
|
|
6
|
Mendelin J, Grayson M, Wallis T, et al:
Analysis of chromosome aneuploidy in breast carcinoma progression
by using fluorescence in situ hybridization. Lab Invest.
79:387–393. 1999.PubMed/NCBI
|
|
7
|
Mark HF, Taylor W, Afify A, et al: Stage I
and stage II infiltrating ductal carcinoma of the breast analyzed
for chromo-some 8 copy number using fluorescent in situ
hybridization. Pathobiology. 65:184–189. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mark HF, Taylor W, Brown S, et al:
Abnormal chromosome 8 copy number in stage I to stage IV breast
cancer studied by fluorescence in situ hybridization. Cancer Genet
Cytogenet. 108:1–5. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Afify A, Bland KI and Mark HFL:
Fluorescent in situ hybridization assessment of chromosome 8 copy
number in breast cancer. Breast Cancer Res Treat. 38:201–208. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Krishnamurthy S, Zhao L, Hayes K, et al:
Feasibility and utility of using chromosomal aneusomy to further
define the cytologic categories in nipple aspirate fluid specimens.
Cancer. 102:322–327. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tavassoli FA and Devilee P: World Health
Organization classification of tumors. Pathology and genetics of
tumors of the breast and female genital organs Lyon, France: IARC
Press; 2003
|
|
12
|
Peter Rosen Paul: Breast Pathology,
Diagnosis by Needle Core Biopsy. 2nd edition. Lippincontt
Williams/Wilkins; Baltimore, MD, USA: pp. 84–123. 2006, PubMed/NCBI
|
|
13
|
Guo SW and Thompson EA: Technical Report
No. 187. Departmental of Statistics, University of Washington;
1989
|
|
14
|
Park SY, Gönen M, Kim HJ, et al: Cellular
and genetic diversity in the progression of in situ human breast
carcinomas to an invasive phenotype. J Clin Invest. 120:401–403.
2010.PubMed/NCBI
|
|
15
|
Botti C, Pescatore B, Mottolese M, et al:
Incidence of chromosomes 1 and 17 aneusomy in breast cancer and
adjacent tissue: an interphase cytogenetic study. J Am Coll Surg.
190:530–539. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ottesen GL, Christensen IJ, Larsen JK, et
al: DNA aneuploidy in early breast cancer. Br J Cancer. 72:832–839.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Aubele M, Cummings M, Walsch A, et al:
Heterogeneous chromosomal aberrations in intraductal breast lesions
adjacent to invasive carcinoma. Anal Cell Pathol. 20:17–24. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu S, Wei B, Zhang H, et al: Evidence of
chromosomal alterations in pure usual ductal hyperplasia as a
breast carcinoma precursor. Oncol Rep. 19:1469–1475.
2008.PubMed/NCBI
|
|
19
|
Kulasingam V and Diamandis E: Strategies
for discovering novel cancer biomarkers through utilization of
emerging technologies. Nat Clin Pract Oncol. 5:588–599. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Roka S, Fiegl M, Zojer N, et al:
Aneuploidy of chromosome 8 as detected by interphase fluorescence
in situ hybridization is a recurrent finding in primary and
metastatic breast cancer. Breast Cancer Res Treat. 48:125–133.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Visscher D, Jimenez RE, Grayson M, et al:
Histopathologic analysis of chromosome aneuploidy in ductal
carcinoma in situ. Hum Pathol. 31:201–207. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Duesberg P, Fabarius A and Hehlmann R:
Aneuploidy, the primary cause of the multilateral genomic
instability of neoplastic and preneoplastic cells. IUBMB Life.
56:65–81. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Deng G, Lu Y, Zlotnikov G, et al: Loss of
heterozygosity in normal tissue adjacent to breast carcinomas.
Science. 274:2057–2059. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Han S, Park K, Shin E, et al: Genomic
change of chromosome 8 predicts the response to taxane-based
neoadjuvant chemotherapy in node-positive breast cancer. Oncol Rep.
24:121–128. 2010.PubMed/NCBI
|
|
25
|
Dey P: Aneuploidy and malignancy: an
unsolved equation. J Clin Pathol. 57:1245–1249. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kovacevic Z and Richardson DR: The
metastasis suppressor, Ndrg-1: a new ally in the fight
against cancer. Carcinogenesis. 27:2355–2366. 2006.PubMed/NCBI
|
|
27
|
Sotelo J, Esposito D, Duhagon MA, et al:
Long-range enhancers on 8q24 regulate c-Myc. Proc Natl Acad Sci
USA. 107:3001–3005. 2010. View Article : Google Scholar : PubMed/NCBI
|
